The importance of choosing the right strategy to treat small cell carcinoma of the cervix: a comparative analysis of treatments

Table 2 Application of chemotherapy, treatment strategy and their outcome by UICC and FIGO stages

		Treatment strategy											Local Failure (%)	Distant Failure (%)	5y-OS (%)
		Surgery only	Local first			NAC			CCRT		Chemo
			SCCC		N-SCCC^b	SCCC		N-SCCC^b	SCCC	N-SCCC	SCCC	N-SCCC
			C	CCRT	N-SCCC^b	C	CCRT	N-SCCC^b	SCCC	N-SCCC	SCCC	N-SCCC
FIGO 2018	I-IIA	11	8	0	2	0	2	0	0	0	0	0	6(26)	8(34)	60%
	IIB-IVA	1	7	4	4	2	2	1	3	9	1	0	5(15)	16(47)	50%
	IVB	0	0	0	0	0	0	0	1	1	5	1	1(13)	NA	NA
Local Failure(%)		4(33)	3(23)	0(0)	2(33)	0(0)		0(0)	0(0)	2(20)	1(17)	0(0)
Distant Failure(%)^a		4(33)	7(41)	1(25)	6(100)	0(0)		1(100)	0(0)	4(57)	NA
5y OS(%)		69	61		NA	100		NA	75	30	NA

SCCC small cell carcinoma of cervix regimen, N-SCCC non-small cell carcinoma of cervix regimen, NA not applicable, OS overall survival, C chemotherapy, CCRT concurrent Chemoradiotherapy
^aPatients with FIGO IVB at diagnosis were excluded from distant failure rate analysis
^bAll patients treated with N-SCCC regimen in local first or NAC had concurrent radiotherapy

ISSN: 1471-2407